Can a new painkiller beat placebo after foot surgery?
NCT ID NCT07807644
First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time
Summary
This Phase 2 trial tests an experimental painkiller called GRT7040 in about 400 adults who have acute pain after bunionectomy, a common foot surgery. Participants receive one of three doses of GRT7040, a placebo, or a standard painkiller (hydrocodone/acetaminophen) for up to 48 hours after surgery. Researchers measure pain relief using a 0-to-10 scale and track side effects to see if GRT7040 is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- GRT7040, an experimental painkiller tested at three doses
- What this could lead to
- If GRT7040 works, it could offer a new option for managing moderate-to-severe acute pain after surgery, possibly with fewer side effects than current opioids.
- What could go wrong
- This is an early Phase 2 trial, so GRT7040 may not prove more effective than placebo or may cause unexpected side effects. Results will need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Adults scheduled for a primary unilateral bunionectomy with distal first metatarsal osteotomy and internal fixation under regional anesthesia. * Able and willing to provide informed consent and comply with study procedures. * Body weight ≥50 kg and BMI 18 to 40 kg/m². * Medically fit for surgery and study treatment based on medical history, physical examination, ECG, vital signs, and laboratory assessments. * Meets protocol-specified contraception requirements. * After surgery, reports moderate to severe pain (Verbal Rating Scale) with a Numeric Pain Rating Scale (NPRS) score ≥4 within 9 hours after removal of the popliteal sciatic block. * Able to follow commands and has complied with protocol-required perioperative analgesic guidelines. Exclusion Criteria * Clinically significant medical conditions or laboratory abnormalities that could increase risk or interfere with study assessments. * Major surgery within 6 months prior to screening or anticipated need for major surgery during the study. * Prior bunionectomy or related surgery on either applicable foot. * Peripheral neuropathy affecting the legs. * Clinically significant cardiac disease, arrhythmias, QT prolongation risk, or abnormal ECG findings. * Sleep apnea requiring positive airway pressure therapy. * American Society of Anesthesiologists (ASA) physical status classification ≥3. * Contraindication, intolerance, allergy, or unwillingness to receive study-related analgesics, NSAIDs, acetaminophen/hydrocodone, local anesthetics, or study drug components. * Participation in another interventional clinical trial within the protocol-defined exclusion period. * Significant renal impairment, hepatic impairment, positive HIV, hepatitis B, or hepatitis C tests. * History of substance abuse or addiction within the previous 3 years or positive drug/alcohol screening as specified by the protocol. * Blood or plasma donation exceeding protocol limits before screening. * Pregnant, breastfeeding, planning pregnancy during the study, or unwilling to comply with contraception requirements. * Postoperative factors precluding randomization, including unsuccessful popliteal block placement, surgical complications, non-adherence to postoperative analgesic requirements, or medical complications during surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute pain are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a heavy blanket calm pain and anxiety after trauma?
- Can a Non-Opioid pill ease pain after ankle replacement?
- Can we predict severe pain after C-Section?
- Can a VR headset turn painful joint injections into a distraction game for kids?
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Your genes may hold the key to predicting Post-Surgical pain